SUNY - Upstate Medical University Div. of Hematology-Oncology — Syracuse, New York

SUNY - Upstate Medical University Div. of Hematology-Oncology is a clinical research site located in Syracuse, New York, United States 13210.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

SUNY - Upstate Medical University Div. of Hematology-Oncology has participated in 3 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Multiple Myeloma, Metastatic Renal Cell Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Syracuse

Browse all research sites in New York · View every site in Syracuse

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SUNY - Upstate Medical University Div. of Hematology-Oncology?

SUNY - Upstate Medical University Div. of Hematology-Oncology has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SUNY - Upstate Medical University Div. of Hematology-Oncology conducted?

SUNY - Upstate Medical University Div. of Hematology-Oncology has 3 clinical trials on record. Their work covers Renal Cell Carcinoma, Multiple Myeloma, Metastatic Renal Cell Carcinoma.

Is SUNY - Upstate Medical University Div. of Hematology-Oncology accredited by Crixeo Clinical Trials?

SUNY - Upstate Medical University Div. of Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SUNY - Upstate Medical University Div. of Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.